ASND
Ascendis Pharma A/S
Company Overview
| Mkt Cap | $12.50B | Price | $201.60 |
| Volume | 314.36K | Change | -1.04% |
| P/E Ratio | -33.1 | Open | $202.83 |
| Revenue | $363.6M | Prev Close | $203.71 |
| Net Income | $-378.1M | 52W Range | $118.03 - $216.45 |
| Div Yield | N/A | Target | $254.25 |
| Overall | 55 | Value | -- |
| Quality | 60 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyAscendis Pharma A/S (ASND) is a leading Healthcare company in the Biotechnology industry, currently trading at $201.60 with a market capitalization of $12.50 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ASND with a volume of 314K shares. The stock opened down 0.43% from yesterday's close of $203.71. Current analyst estimates project earnings of $-2.98 per share for this year, with next year targeting $3.17.
ASND demonstrates neutral technical outlook based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including AFMD, AGEN, ADXS, AGTC.
Key investment considerations for ASND include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 26.1%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:48 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $201.60 | -1.0% | 314.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |